Clinical Trial: Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly

U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT06788236) titled 'Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly' on Dec. 11, 2024.

Brief Summary: The goal of this clinical trial is to primarily evaluate the efficacy of AVTR101 to placebo on physical performance in sarcopenia patients.

Participants will:

Take AVTR101 or a placebo three times daily for 12 weeks Visit the clinic once every 4 weeks for checkups and tests

Study Start Date: May 23, 2022

Study Type: INTERVENTIONAL

Condition: Sarcopenia

Intervention: DRUG: AVTR101

three times daily

DRUG: Placebo

three times daily

Recruitment Status: TERMINATED

Sponsor: Aventi Biotechnology Inc.

Published by HT Digital Content...